(+)-catechin multiple interactions ISO RGD:1345927 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of KLF5 mRNA CTD PMID:24763279 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of KLF5 mRNA] CTD PMID:31150632 (2,4,5-trichlorophenoxy)acetic acid increases expression ISO RGD:1551083 6480464 2 more ... CTD PMID:18579281 1,2,4-trimethylbenzene decreases expression EXP 6480464 pseudocumene results in decreased expression of KLF5 protein CTD PMID:17337753 1,2-dimethylhydrazine multiple interactions ISO RGD:1551083 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KLF5 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:1551083 6480464 Ethinyl Estradiol results in increased expression of KLF5 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:1345927 6480464 Estradiol results in decreased expression of KLF5 mRNA CTD PMID:19167446 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of KLF5 mRNA CTD PMID:26496021 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1345927 6480464 Dihydrotestosterone results in increased expression of KLF5 mRNA CTD PMID:29581250 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1551083 6480464 Tetrachlorodibenzodioxin results in increased expression of KLF5 mRNA CTD PMID:18691609 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of KLF5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of KLF5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1345927 6480464 Tetrachlorodibenzodioxin results in increased expression of KLF5 mRNA CTD PMID:12377990 , PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551083 6480464 Tetrachlorodibenzodioxin affects the expression of KLF5 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1345927 6480464 Tetrachlorodibenzodioxin affects the expression of KLF5 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of KLF5 mRNA CTD PMID:20558275 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1551083 6480464 [Tetrachlorodibenzodioxin affects the methylation of KLF5 intron] which results in decreased expression of KLF5 mRNA more ... CTD PMID:16054899 more ... 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of KLF5 mRNA CTD PMID:30071829 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1551083 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of KLF5 mRNA more ... CTD PMID:16054899 more ... 3-methylcholanthrene increases expression ISO RGD:1551083 6480464 Methylcholanthrene results in increased expression of KLF5 mRNA CTD PMID:20713471 4-hydroxyphenyl retinamide increases expression ISO RGD:1551083 6480464 Fenretinide results in increased expression of KLF5 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1345927 6480464 [Decitabine co-treated with trichostatin A] results in increased expression of KLF5 mRNA CTD PMID:20678512 5-fluorouracil multiple interactions ISO RGD:1345927 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of KLF5 mRNA] CTD PMID:15016801 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of KLF5 mRNA CTD PMID:24780913 acrolein multiple interactions ISO RGD:1345927 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of KLF5 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of KLF5 mRNA CTD PMID:32699268 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of KLF5 mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:1345927 6480464 Acrylamide results in increased expression of KLF5 mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:1345927 6480464 Aflatoxin B1 affects the expression of KLF5 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of KLF5 mRNA CTD PMID:23630614 aflatoxin B1 increases expression ISO RGD:1345927 6480464 Aflatoxin B1 results in increased expression of KLF5 mRNA CTD PMID:22100608 all-trans-retinoic acid increases expression ISO RGD:1345927 6480464 Tretinoin results in increased expression of KLF5 mRNA CTD PMID:21934132 all-trans-retinoic acid multiple interactions ISO RGD:1551083 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of KLF5 mRNA CTD PMID:30951980 alpha-pinene multiple interactions ISO RGD:1345927 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of KLF5 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of KLF5 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of KLF5 mRNA CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1551083 6480464 pyrazolanthrone inhibits the reaction [Ozone results in increased expression of KLF5 mRNA] CTD PMID:17460151 antimonite multiple interactions ISO RGD:1345927 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KLF5 mRNA CTD PMID:32076005 antimycin A increases expression ISO RGD:1345927 6480464 Antimycin A results in increased expression of KLF5 mRNA CTD PMID:33512557 arachidonic acid increases expression ISO RGD:1345927 6480464 Arachidonic Acid results in increased expression of KLF5 mRNA CTD PMID:16704987 aristolochic acid A increases expression ISO RGD:1345927 6480464 aristolochic acid I results in increased expression of KLF5 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1345927 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Benzo(a)pyrene] results in increased expression of KLF5 protein, MCL1 protein affects the reaction [[[sodium arsenite results in increased abundance of Arsenic] which co-treated with Benzo(a)pyrene] results in increased expression of KLF5 protein] CTD PMID:32802178 arsenic atom multiple interactions ISO RGD:1345927 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Benzo(a)pyrene] results in increased expression of KLF5 protein, MCL1 protein affects the reaction [[[sodium arsenite results in increased abundance of Arsenic] which co-treated with Benzo(a)pyrene] results in increased expression of KLF5 protein] CTD PMID:32802178 arsenite(3-) increases expression ISO RGD:1551083 6480464 arsenite results in increased expression of KLF5 mRNA CTD PMID:15868481 arsenite(3-) multiple interactions ISO RGD:1345927 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of KLF5 mRNA CTD PMID:32076005 arsenous acid increases expression ISO RGD:1345927 6480464 Arsenic Trioxide results in increased expression of KLF5 mRNA CTD PMID:15761015 , PMID:20458559 arsenous acid decreases response to substance ISO RGD:1345927 6480464 KLF5 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of KLF5 gene CTD PMID:28931070 azathioprine increases expression ISO RGD:1345927 6480464 Azathioprine results in increased expression of KLF5 mRNA CTD PMID:22623647 baicalein decreases expression ISO RGD:1551083 6480464 baicalein results in decreased expression of KLF5 mRNA CTD PMID:24560969 belinostat increases expression ISO RGD:1345927 6480464 belinostat results in increased expression of KLF5 mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:1345927 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF5 mRNA CTD PMID:27188386 benzo[a]pyrene multiple interactions ISO RGD:1551083 6480464 Benzo(a)pyrene affects the reaction [AHR protein binds to KLF5 promoter] CTD PMID:19654925 benzo[a]pyrene multiple interactions ISO RGD:1345927 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Benzo(a)pyrene] results in increased expression of KLF5 protein, MCL1 protein affects the reaction [[[sodium arsenite results in increased abundance of Arsenic] which co-treated with Benzo(a)pyrene] results in increased expression of KLF5 protein] CTD PMID:32802178 benzo[a]pyrene decreases expression ISO RGD:1345927 6480464 Benzo(a)pyrene results in decreased expression of KLF5 protein CTD PMID:32717239 benzo[a]pyrene decreases expression ISO RGD:1551083 6480464 Benzo(a)pyrene results in decreased expression of KLF5 mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:1345927 6480464 Benzo(a)pyrene results in increased expression of KLF5 mRNA CTD PMID:20064835 more ... benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of KLF5 mRNA CTD PMID:21839799 benzo[a]pyrene increases expression ISO RGD:1551083 6480464 Benzo(a)pyrene results in increased expression of KLF5 mRNA CTD PMID:20713471 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1345927 6480464 7 more ... CTD PMID:19150397 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1345927 6480464 Diethylhexyl Phthalate results in increased expression of KLF5 mRNA CTD PMID:31163220 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of KLF5 mRNA CTD PMID:26496021 bisphenol A increases expression ISO RGD:1551083 6480464 bisphenol A results in increased expression of KLF5 mRNA CTD PMID:32156529 bisphenol A affects methylation ISO RGD:1551083 6480464 bisphenol A affects the methylation of KLF5 promoter CTD PMID:27334623 bisphenol A decreases expression ISO RGD:1345927 6480464 bisphenol A results in decreased expression of KLF5 mRNA CTD PMID:20678512 , PMID:27685785 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of KLF5 mRNA CTD PMID:25181051 , PMID:33296240 Bisphenol A diglycidyl ether multiple interactions EXP 6480464 2 more ... CTD PMID:25874449 bisphenol F multiple interactions ISO RGD:1551083 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of KLF5 mRNA CTD PMID:30951980 boric acid multiple interactions ISO RGD:1551083 6480464 boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of KLF5 mRNA] CTD PMID:28285642 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of KLF5 mRNA CTD PMID:22110744 cadmium dichloride increases expression ISO RGD:1345927 6480464 Cadmium Chloride results in increased expression of KLF5 mRNA CTD PMID:26472689 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of KLF5 mRNA CTD PMID:33453195 calcitriol multiple interactions ISO RGD:1345927 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of KLF5 mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1345927 6480464 Calcitriol results in increased expression of KLF5 mRNA CTD PMID:21592394 , PMID:26485663 carbon nanotube decreases expression ISO RGD:1551083 6480464 Nanotubes, Carbon results in decreased expression of KLF5 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1345927 6480464 Nanotubes, Carbon results in increased expression of KLF5 mRNA CTD PMID:31047983 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of KLF5 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:1551083 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KLF5 mRNA CTD PMID:20938992 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of KLF5 mRNA CTD PMID:24386269 cocaine affects expression EXP 6480464 Cocaine affects the expression of KLF5 mRNA CTD PMID:20187946 copper atom increases expression ISO RGD:1345927 6480464 Copper results in increased expression of KLF5 mRNA CTD PMID:19747488 copper(0) increases expression ISO RGD:1345927 6480464 Copper results in increased expression of KLF5 mRNA CTD PMID:19747488 copper(II) sulfate increases expression ISO RGD:1345927 6480464 Copper Sulfate results in increased expression of KLF5 mRNA CTD PMID:19549813 copper(II) sulfate increases expression ISO RGD:1551083 6480464 Copper Sulfate results in increased expression of KLF5 mRNA CTD PMID:18579281 cucurbitacin B increases expression ISO RGD:1551083 6480464 cucurbitacin B results in increased expression of KLF5 CTD PMID:24316209 cucurbitacin I increases expression ISO RGD:1551083 6480464 cucurbitacin I results in increased expression of KLF5 CTD PMID:24316209 cumene multiple interactions ISO RGD:1551083 6480464 [cumene co-treated with KRAS gene mutant form] results in increased expression of KLF5 mRNA CTD PMID:18648096 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of KLF5 mRNA CTD PMID:26577399 Curcumol multiple interactions ISO RGD:1551083 6480464 KLF5 protein inhibits the reaction [curcumol inhibits the reaction [Carbon Tetrachloride results in increased activity of GPT protein]] more ... CTD PMID:33549628 Curcumol multiple interactions EXP 6480464 [KLF5 protein co-treated with curcumol] inhibits the reaction [VEGFA protein results in increased expression of ANGPT2 protein] more ... CTD PMID:33549628 cyclophosphamide affects response to substance ISO RGD:1345927 6480464 KLF5 protein affects the susceptibility to Cyclophosphamide CTD PMID:16217747 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of KLF5 mRNA CTD PMID:21865292 cyclosporin A decreases expression ISO RGD:1345927 6480464 Cyclosporine results in decreased expression of KLF5 mRNA CTD PMID:27989131 cyclosporin A increases expression ISO RGD:1345927 6480464 Cyclosporine results in increased expression of KLF5 mRNA CTD PMID:20106945 , PMID:25562108 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of KLF5 mRNA CTD PMID:23914054 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of KLF5 mRNA CTD PMID:23640034 dexamethasone multiple interactions ISO RGD:1551083 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of KLF5 mRNA more ... CTD PMID:16054899 more ... dexamethasone increases expression ISO RGD:1551083 6480464 Dexamethasone results in increased expression of KLF5 mRNA CTD PMID:21041162 diarsenic trioxide decreases response to substance ISO RGD:1345927 6480464 KLF5 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 diarsenic trioxide increases expression ISO RGD:1345927 6480464 Arsenic Trioxide results in increased expression of KLF5 mRNA CTD PMID:15761015 , PMID:20458559 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of KLF5 mRNA CTD PMID:21266533 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO RGD:1345927 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KLF5 mRNA CTD PMID:32076005 dorsomorphin multiple interactions ISO RGD:1345927 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:1345927 6480464 KLF5 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 , PMID:32173973 doxorubicin multiple interactions ISO RGD:1345927 6480464 Doxorubicin promotes the reaction [KLF5 protein affects the phosphorylation of MAPK8 protein] more ... CTD PMID:32173973 doxorubicin decreases phosphorylation ISO RGD:1345927 6480464 Doxorubicin results in decreased phosphorylation of KLF5 protein CTD PMID:32173973 doxorubicin decreases expression ISO RGD:1345927 6480464 Doxorubicin results in decreased expression of KLF5 mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:1345927 6480464 Doxorubicin results in increased expression of KLF5 mRNA CTD PMID:28940058 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of KLF5 mRNA CTD PMID:29391264 etoposide increases expression ISO RGD:1345927 6480464 Etoposide results in increased expression of KLF5 mRNA CTD PMID:29397400 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of KLF5 mRNA CTD PMID:18035473 fluoranthene multiple interactions ISO RGD:1551083 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF5 mRNA, SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF5 mRNA] CTD PMID:28329830 folic acid multiple interactions ISO RGD:1551083 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folic acid decreases expression ISO RGD:1551083 6480464 Folic Acid results in decreased expression of KLF5 mRNA CTD PMID:25629700 furan increases methylation EXP 6480464 furan results in increased methylation of KLF5 gene CTD PMID:22079235 furan increases expression EXP 6480464 furan results in increased expression of KLF5 mRNA CTD PMID:27387713 genistein decreases expression ISO RGD:1551083 6480464 Genistein results in decreased expression of KLF5 mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of KLF5 mRNA CTD PMID:33387578 geraniol increases expression ISO RGD:1345927 6480464 geraniol results in increased expression of KLF5 mRNA CTD PMID:27683099 hydrogen peroxide affects expression ISO RGD:1345927 6480464 Hydrogen Peroxide affects the expression of KLF5 mRNA CTD PMID:20044591 kojic acid increases expression ISO RGD:1345927 6480464 kojic acid results in increased expression of KLF5 mRNA CTD PMID:16595896 L-methionine multiple interactions ISO RGD:1551083 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KLF5 mRNA CTD PMID:20938992 leflunomide increases expression ISO RGD:1345927 6480464 leflunomide results in increased expression of KLF5 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions ISO RGD:1345927 6480464 [Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of KLF5 mRNA more ... CTD PMID:26667767 , PMID:35811015 lipopolysaccharide increases expression ISO RGD:1345927 6480464 Lipopolysaccharides results in increased expression of KLF5 mRNA CTD PMID:35811015 manganese(II) chloride decreases expression ISO RGD:1551083 6480464 manganese chloride results in decreased expression of KLF5 mRNA CTD PMID:17467022 manganese(II) chloride decreases methylation EXP 6480464 manganese chloride results in decreased methylation of KLF5 gene CTD PMID:28801915 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of KLF5 mRNA CTD PMID:28801915 mercury dibromide increases expression ISO RGD:1345927 6480464 mercuric bromide results in increased expression of KLF5 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1345927 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF5 mRNA CTD PMID:27188386 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of KLF5 mRNA CTD PMID:19564919 methylisothiazolinone increases expression ISO RGD:1345927 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of KLF5 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1345927 6480464 methylmercuric chloride results in increased expression of KLF5 mRNA CTD PMID:28001369 methylmercury chloride decreases expression ISO RGD:1345927 6480464 methylmercuric chloride results in decreased expression of KLF5 mRNA CTD PMID:34328791 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of KLF5 mRNA CTD PMID:18095165 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of KLF5 mRNA CTD PMID:22110744 ozone multiple interactions ISO RGD:1551083 6480464 pyrazolanthrone inhibits the reaction [Ozone results in increased expression of KLF5 mRNA] CTD PMID:17460151 ozone multiple interactions ISO RGD:1345927 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of KLF5 mRNA more ... CTD PMID:32699268 p-chloromercuribenzoic acid increases expression ISO RGD:1345927 6480464 p-Chloromercuribenzoic Acid results in increased expression of KLF5 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1345927 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF5 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1345927 6480464 panobinostat results in increased expression of KLF5 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1345927 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF5 mRNA CTD PMID:27188386 paracetamol decreases expression ISO RGD:1551083 6480464 Acetaminophen results in decreased expression of KLF5 mRNA CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of KLF5 mRNA CTD PMID:33387578 paracetamol affects expression ISO RGD:1345927 6480464 Acetaminophen affects the expression of KLF5 mRNA CTD PMID:25458485 paracetamol increases expression ISO RGD:1345927 6480464 Acetaminophen results in increased expression of KLF5 mRNA CTD PMID:21420995 , PMID:29067470 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 perfluorooctanoic acid increases expression ISO RGD:1345927 6480464 perfluorooctanoic acid results in increased expression of KLF5 mRNA CTD PMID:25868421 perfluorooctanoic acid multiple interactions ISO RGD:1345927 6480464 perfluorooctanoic acid inhibits the reaction [Progesterone affects the expression of KLF5 mRNA], Progesterone inhibits the reaction [perfluorooctanoic acid inhibits the reaction [Progesterone affects the expression of KLF5 mRNA]] CTD PMID:31896193 perfluorooctanoic acid increases activity ISO RGD:1345927 6480464 perfluorooctanoic acid results in increased activity of KLF5 protein CTD PMID:27589886 phenylmercury acetate increases expression ISO RGD:1345927 6480464 Phenylmercuric Acetate results in increased expression of KLF5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1345927 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF5 mRNA CTD PMID:27188386 phosgene affects expression ISO RGD:1551083 6480464 Phosgene affects the expression of KLF5 mRNA CTD PMID:16300373 pioglitazone multiple interactions EXP 6480464 Pioglitazone inhibits the reaction [AGT protein results in increased expression of KLF5 mRNA], Pioglitazone inhibits the reaction [AGT protein results in increased expression of KLF5 protein] CTD PMID:25874449 progesterone increases expression ISO RGD:1345927 6480464 Progesterone results in increased expression of KLF5 mRNA CTD PMID:18037150 , PMID:18070364 progesterone multiple interactions ISO RGD:1345927 6480464 perfluorooctanoic acid inhibits the reaction [Progesterone affects the expression of KLF5 mRNA], Progesterone inhibits the reaction [perfluorooctanoic acid inhibits the reaction [Progesterone affects the expression of KLF5 mRNA]] CTD PMID:31896193 progesterone affects expression ISO RGD:1345927 6480464 Progesterone affects the expression of KLF5 mRNA CTD PMID:31896193 Ptaquiloside decreases expression ISO RGD:1551083 6480464 ptaquiloside results in decreased expression of KLF5 mRNA CTD PMID:23274088 quercetin increases expression ISO RGD:1345927 6480464 Quercetin results in increased expression of KLF5 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1345927 6480464 [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of KLF5 mRNA CTD PMID:26667767 rifampicin multiple interactions ISO RGD:1345927 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of KLF5 mRNA CTD PMID:21127053 rotenone decreases expression ISO RGD:1345927 6480464 Rotenone results in decreased expression of KLF5 mRNA CTD PMID:29955902 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1345927 6480464 [S-(1 more ... CTD PMID:35811015 SB 203580 multiple interactions ISO RGD:1345927 6480464 SB 203580 inhibits the reaction [TGFB1 protein results in decreased expression of KLF5 mRNA] CTD PMID:21712382 SB 203580 multiple interactions ISO RGD:1551083 6480464 SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of KLF5 mRNA] CTD PMID:28329830 SB 431542 multiple interactions ISO RGD:1345927 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SCH 23390 decreases expression EXP 6480464 SCH 23390 results in decreased expression of KLF5 mRNA CTD PMID:19564919 silibinin multiple interactions ISO RGD:1551083 6480464 Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of KLF5 mRNA] CTD PMID:25559859 silver atom increases expression ISO RGD:1345927 6480464 Silver results in increased expression of KLF5 mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:1345927 6480464 Silver results in increased expression of KLF5 mRNA CTD PMID:26014281 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of KLF5 mRNA CTD PMID:21865292 sodium arsenate increases expression ISO RGD:1551083 6480464 sodium arsenate results in increased expression of KLF5 mRNA CTD PMID:21795629 sodium arsenite increases expression ISO RGD:1345927 6480464 sodium arsenite results in increased expression of KLF5 mRNA CTD PMID:12760830 sodium arsenite multiple interactions ISO RGD:1345927 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Benzo(a)pyrene] results in increased expression of KLF5 protein more ... CTD PMID:32076005 , PMID:32802178 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of KLF5 mRNA CTD PMID:22110744 Soman increases expression EXP 6480464 Soman results in increased expression of KLF5 mRNA CTD PMID:19281266 sulindac increases expression ISO RGD:1345927 6480464 Sulindac results in increased expression of KLF5 mRNA CTD PMID:11906190 sunitinib increases expression ISO RGD:1345927 6480464 Sunitinib results in increased expression of KLF5 mRNA CTD PMID:31533062 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of KLF5 mRNA CTD PMID:21865292 tamibarotene multiple interactions ISO RGD:1345927 6480464 tamibarotene inhibits the reaction [[KLF5 protein binds to [RARA protein binds to RXRA protein]] which binds to PDGFA promoter] more ... CTD PMID:16224062 tebufenpyrad increases expression ISO RGD:1345927 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of KLF5 mRNA CTD PMID:33512557 testosterone multiple interactions ISO RGD:1345927 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of KLF5 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1345927 6480464 Testosterone results in decreased expression of KLF5 mRNA CTD PMID:33359661 testosterone increases expression ISO RGD:1345927 6480464 Testosterone results in increased expression of KLF5 mRNA CTD PMID:21592394 tetrachloromethane multiple interactions ISO RGD:1551083 6480464 KLF5 protein inhibits the reaction [curcumol inhibits the reaction [Carbon Tetrachloride results in increased activity of GPT protein]] more ... CTD PMID:33549628 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of KLF5 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of KLF5 mRNA CTD PMID:31150632 tetraphene decreases expression ISO RGD:1551083 6480464 benz(a)anthracene results in decreased expression of KLF5 mRNA CTD PMID:26377693 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of KLF5 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1551083 6480464 titanium dioxide results in decreased expression of KLF5 mRNA CTD PMID:23557971 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of KLF5 mRNA CTD PMID:25729387 triacsin C increases expression ISO RGD:1345927 6480464 triacsin C results in increased expression of KLF5 mRNA CTD PMID:16704987 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of KLF5 mRNA CTD PMID:33387578 trichostatin A multiple interactions ISO RGD:1345927 6480464 [Decitabine co-treated with trichostatin A] results in increased expression of KLF5 mRNA more ... CTD PMID:20678512 , PMID:27188386 trichostatin A increases expression ISO RGD:1345927 6480464 trichostatin A results in increased expression of KLF5 mRNA CTD PMID:20678512 more ... tunicamycin increases expression ISO RGD:1345927 6480464 Tunicamycin results in increased expression of KLF5 mRNA CTD PMID:33545341 undecane decreases expression EXP 6480464 undecane results in decreased expression of KLF5 protein CTD PMID:17337753 urethane increases expression ISO RGD:1345927 6480464 Urethane results in increased expression of KLF5 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:1551083 6480464 Valproic Acid results in increased expression of KLF5 mRNA CTD PMID:21427059 valproic acid multiple interactions ISO RGD:1345927 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF5 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1345927 6480464 Valproic Acid results in increased expression of KLF5 mRNA CTD PMID:23179753 more ... valproic acid decreases expression ISO RGD:1551083 6480464 Valproic Acid results in decreased expression of KLF5 mRNA CTD PMID:19136453 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of KLF5 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of KLF5 mRNA CTD PMID:23034163 , PMID:23555832